UNSPSC 51162312: Acetaminophen/chlorpheniramine/phenylephrine/salicylamide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162312 Acetaminophen/chlorpheniramine/phenylephrine/salicylamide (Commodity) covers pharmaceutical and over-the-counter combination pain and cold-relief products procured by state and local health agencies, counties, and cooperative purchasing alliances for distribution through public health systems and authorized wholesaler networks. State and local buyers under this code source multi-source generic formulations and branded equivalents through competitive bidding, with products typically distributed to community health facilities, public health departments, and networked provider locations. The issuing-body mix includes county health departments, state purchasing offices, and multistate cooperative purchasing organizations that aggregate demand across multiple jurisdictions to achieve volume pricing and standardized supply-chain management.

Recent opportunities reflect two distinct procurement patterns: Seminole County, Florida issued an IFB (solicitation IFB60459723LAS, due July 26, 2023) for 1,900 units of Naloxone annually alongside Safe Drug Deactivation Systems through its community health building, with quarterly deliveries and electronic bidding required through the county e-Procurement Portal. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802, due March 26, 2026) to establish multi-award contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities, including Oregon, through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, Morris & Dickson Co., LLC), with contracts effective July 1, 2026. Geographic activity centers on Florida and Minnesota–based procurement, with MMCAP's scope extending across multiple states participating in the cooperative vehicle. Vendors must meet cGMP and DSCSA compliance, maintain relationships with authorized wholesalers, provide NDC-specific pricing, and carry commercial general liability insurance of at least $5,000,000 per occurrence.